\chapter{\label{ch:5-results_dose}Systems approaches to understand drug resistance in a multiple myeloma cell model}
% Chapter of dose responses and validation of screen

\section{Introduction}\label{sec:systems_intro}

\section{Results}\label{sec:systems_results}


\subsection{Transcriptional changes in drug resistance}\label{subsec:systems_transcriptomics}
% subsubsection of WT DMSO vs WT carf (what carf action usually does??)

To investigate the transcriptional changes that underlie the acquired-PI-resistance in multiple myeloma a number of RNA-seq experiments to compare WT, carfilzomib resistant (aCFZ) and bortezomib (aBTZ) AMO-1 cells were performed, both at the bulk and single-cell level. 

\subsection{Proteomics changes in drug resistance}\label{subsec:systems_proteomics}


\subsection{Epigenetic changes in drug resistance}\label{subsec:systems_epigenetics}

